Skip to main content
OpenTrials
Completed

NCT Number: NCT05463484

Effects of a Composition on the Oral Microbiome, pH, Nitrite/Nitrate Ratio, Elastases and Inflammation in Oral Dysbiosis

Dysbiosis is a condition in which the normal function of an ecological net is altered. In dysbiosis a state of inflammation, a loss of hydration, a change in pH, a loss of the barrier function are all allies of key pathogens that initiate invasion and cytokine and pro-inflammatory mediators release that target other tissues and organs resulting in chronic inflammatory conditions.

In health there is a cross-talk between the host and the microbiota in order to maintain and promote a state of eubiosis with a local and general health gain. Dysbiosis reversion has not been solved with the use of antibacterials, antiseptics nor antibiotics.

Stop dysbiosis project is focussed on different aspects of human dysbiosis such as oral dysbiosis, skin dysbiosis, vaginal dysbiosis and cancer dysbiosis, between others including the current prospective interventional double-blind randomised clinical trial.

One of the most common oral dysbiosis is periodontal and mucosa dysbiosis that courses with inflammation of the gingiva (gingivitis). This inflammation induces specific enzymes that in a later stage destroy connective tissue. The current clinical trial analyzes the effect of a composition (Saliactive ®) delivered to the oral cavity via a daily use toothpaste (YOTUEL® microbiome toothpaste) in a group of patients with oral dysbiosis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Departamento de Estomatología, Facultad de Odontología

Granada, 18071, Spain

About this study

Oral microbiota is the most diverse of the human body. It consists of mainly commensal bacteria, archea, protozoos, yeast and funghi. More than 700 species of bacteria have been identified in the mouth. In conditions of health these bacteria live in equilibrium. In inflammatory conditions, balance is lost, due to changes in microbiota or in the ecosystem with lost of the mucosa barrier function. If dysbiosis appears pathogen or fragments of these or toxic agents penetrate the body orchestrating a deep alteration of vital functions such as immune defense, nitric oxide pathways, cell cycle regulation and redox balance.

Periodontal dysbiosis is the consequence of the accumulation of plaque and the increase of gram negative species capable of releasing virulence factors that maintain inflammation and bleeding that perpetuate a disease-promoting ecosystem.

Oral hygiene is a daily personal protocol for effective delivery of active substances to the tissues of the oral cavity, mainly fluoride and antiseptics. The standard of care in the oral compound is toothpaste used 2-3 times a day.

The test toothpaste including Saliactive® (an olive product, betaine and xylitol) does not contain any antimicrobial agent nor antiseptic. A randomized, double-blind controlled clinical trial in 100 patients will evaluate the efficacy to reverse oral dysbiosis. Microbiota profile through genetic sequenciation of the rDNA16s, inflammatory markers, nitrate reducing bacteria abundance, nitrite/nitrate ratio, pH, plaque and bleeding index will be evaluated at baseline, after 2 months and 4 months of exposure to the assigned composition. Two controls will be analysed, one fluoridated placebo but without the 3 active ingredients olive product, betaine and xylitol (Saliactive®), and a fluoridated commercial toothpaste for gingivitis with zinc citrate. Assignation of the 100 subjects will be randomized and the products are blind for the subjects and the researcher.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnose of gingivitis.
  • At least 20 teeth (3rd molars excluded).
  • Must Accept informed consent.

Exclusion criteria

  • Clinical diagnose of periodontitis.
  • With orthodontics.
  • With removable dentures.
  • With upper incisors restorated.
  • Tumours in soft or hard tissues of the mouth.
  • More than 5 caries lesions with immediate restorative need
  • Antibiotics intake less than one month ago.
  • Pregnant women.
  • Other clinic assay at the moment.
  • Dental prophylaxis less than 2 weeks before starting the study.

Treatment and study plan

Test composition Saliactive® (olive product, betaine and xylitol)

Drug

Fluoridated toothpaste with Saliactive®.

Other names: Saliactive®

Placebo

Drug

Fluoridated toothpaste without Saliactive®.

Other names: Placebo fluoridated toothpaste without the test composition

Control

Drug

Commercial Fluoridated toothpaste for gingivitis with zinc citrate.

Other names: Control commercial Fluoridated toothpaste for gingivitis with zinc citrate.

Primary outcomes

  1. Oral microbiota profile at baseline and after 4 months

    Time frame: 4 months

    16s rDNA genetic sequencing

  2. Oral pH at baseline and after 4 months

    Time frame: 4 months

    pH meter

  3. Nitrite/Nitrate ratio at baseline and after 4 months

    Time frame: 4 months

    Ionic chromatography

  4. Elastase at baseline at 2 months and at 4 months

    Time frame: 4 months

    ELISA

  5. Bleeding index at baseline, at 2 months and at 4 months

    Time frame: 4 months

    Ainamo and Bay bleeding index indicating the percentage of bleeding from 0 (no bleeding) to 100 (maximum bleeding)

  6. Plaque index at baseline, at 2 months and at 4 months

    Time frame: 4 months

    Tonetti plaque index

Secondary outcomes

  1. Salivary flow rate at baseline, 2 months and at 4 months

    Time frame: 4 months

    Unstimulated salivary flow rate recovery as per Navazesh

Other outcomes

  1. Tooth colour at baseline and at 4 months

    Time frame: 4 months

    VITA Easyshade® V

Sponsors and collaborators

Lead sponsor

Mucosa Innovations, S.L.

Industry

Collaborators

  • Universidad de Granada

Registry information

Official study title

Effects of a Composition Delivered Via Toothpaste on the Oral Microbiome, pH, Nitrite/Nitrate Ratio, Elastases, and Inflammation in Patients With Oral Dysbiosis: A Controlled, Randomized, Double-blind Study. Part of Stop Dysbiosis Project

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Jul 19, 2022
Registry last updated
Jul 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.